EU-JAMRAI is a European Joint Action on Antimicrobial Resistance (AMR) and Healthcare-Associated Infections (HCAI) that was active from 2018 through 2021. It brought together 44 partners and more than 40 stakeholders, including the Global AMR R&D Hub. The mission was to foster synergies among EU Member States by developing and implementing effective One Health policies to fight the rising threat of AMR and to reduce HCAI.
EU-JAMRAI was co-funded by the Health Programme of the European Union under Grant Agreement No. 761296.
To ensure that project results remain available, alongside other stakeholders the Global AMR R&D Hub as agreed to host documents that are relevant to its remit on this website.
The documents are:
- Gathering of national research priorities from France, Greece, the Netherlands, Norway, Slovenia, Spain and the United Kingdom and gap identification
- Publication on Financing Pull Mechanisms for Antibiotic-Related Innovation: Opportunities for Europe